Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Small-Cell-Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00200382
What this trial is testing

Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Rasim Gucalp 27
Large-scale testing (Phase 3)Study completedNCT01661790
What this trial is testing

Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer

Who this might be right for
Malignant Pleural Effusion
Chinese PLA General Hospital 72
Large-scale testing (Phase 3)Ended earlyNCT04746924
What this trial is testing

Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer

Who this might be right for
Non-small Cell Lung CancerNSCLC
BeiGene 669
Not applicableNot Yet RecruitingNCT06829641
What this trial is testing

Clinical Outcomes of Tislelizumab Combined With Chemotherapy as Induction Therapy in Stage III (cTNM-IIIB/IIIC) NSCLC

Who this might be right for
NSCLC Stage IIIB, NSCLC Stage IIIC
West China Hospital 200
Testing effectiveness (Phase 2)UnknownNCT04974879
What this trial is testing

Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Qingdao Central Hospital 20
Not applicableUnknownNCT03940846
What this trial is testing

CT-based Radiomic Signature Can Identify Adenocarcinoma Lung Tumor Histology

Who this might be right for
Nonsmall Cell Lung Cancer
Maastricht University 650
Testing effectiveness (Phase 2)Ended earlyNCT00061646
What this trial is testing

Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Abbott 25
Large-scale testing (Phase 3)Study completedNCT00409188
What this trial is testing

Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)

Who this might be right for
Non-small Cell Lung Cancer
EMD Serono 1,513
Testing effectiveness (Phase 2)WithdrawnNCT04944173
What this trial is testing

SCION: SABR and Checkpoint Inhibition of NSCLC

Who this might be right for
Non Small Cell Lung CancerCarcinoma, Non-Small-Cell LungNon-small Cell Lung Cancer Stage I+4 more
University of British Columbia
Not applicableUnknownNCT03680183
What this trial is testing

Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV)

Who this might be right for
Non Small Cell Lung CancerHepatitis B
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 300
Large-scale testing (Phase 3)Active Not RecruitingNCT05450692
What this trial is testing

A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy

Who this might be right for
Advanced or Metastatic Non-Small Cell Lung Cancer
AstraZeneca 594
Not applicableStudy completedNCT03095209
What this trial is testing

Observation Study of Patients With Non-Small Cell Lung Cancer and Esophageal Cancer Treated With Chemo-Radiation Followed by Surgery

Who this might be right for
Lung CancerEsophageal Cancer
Fox Chase Cancer Center 6
Large-scale testing (Phase 3)Study completedNCT02613507
What this trial is testing

Efficacy Study of Nivolumab Compared to Docetaxel in Subjects Previously Treated With Advanced or Metastatic Non Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 504
Early research (Phase 1)Ended earlyNCT04005144
What this trial is testing

Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer

Who this might be right for
ALK Gene RearrangementLung Non-Small Cell CarcinomaProgressive Disease+6 more
University of California, San Francisco 3
Large-scale testing (Phase 3)Ended earlyNCT02129699
What this trial is testing

Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy

Who this might be right for
Lung Cancer Non-small Cell Stage IV
ETOP IBCSG Partners Foundation 595
Early research (Phase 1)Active Not RecruitingNCT02496663
What this trial is testing

Osimertinib and Necitumumab in Treating Patients With EGFR-Mutant Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
National Cancer Institute (NCI) 138
Early research (Phase 1)Study completedNCT03516214
What this trial is testing

EGF816 and Trametinib in Patients With Non-small Cell Lung Cancer Harboring Activating EGFR Mutations

Who this might be right for
Bronchial Neoplasms
University of Cologne 18
Testing effectiveness (Phase 2)Study completedNCT00319514
What this trial is testing

Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLC

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Gachon University Gil Medical Center 78
Not applicableLooking for participantsNCT06605404
What this trial is testing

Pan-tumor MRD Study

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaEsophageal CancerGastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+4 more
Paradigm Health 1,350
Large-scale testing (Phase 3)Study completedNCT00074204
What this trial is testing

Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Case Comprehensive Cancer Center 17
Next Page